Brief: Bergenbio Q3 Loss After Tax Widens To NOK 67.3 Million

Oncoinvent ASA

17/11/2020 06:05

Nov 17 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO ASA: THIRD QUARTER 2020 RESULTS
    * REVENUE FOR Q3 OF 2020 AND NINE MONTHS ENDED 30 SEPTEMBER
2020,
RESPECTIVELY, AMOUNTED TO NOK 0.0 MILLION (NOK 0.0 MILLION), AND
NOK 0.0 MILLION (NOK 8.7 MILLION).
    * TOTAL OPERATING EXPENSES FOR Q3 AND NINE MONTHS ENDED 30
SEPTEMBER 2020, RESPECTIVELY, AMOUNTED TO NOK 68.3 MILLION (NOK
47.5 MILLION) AND NOK 189 MILLION (NOK 154.0 MILLION).
    * CASH AND CASH EQUIVALENTS AT END OF Q3 AMOUNTED TO NOK
777.9
MILLION (NOK 289.5 MILLION)
    * Q3 LOSS AFTER TAX NOK 67.3 MILLION VERSUS LOSS NOK 44.6
MILLION
YEAR AGO
    * WITH A NOK 520 MILLION FUNDRAISING COMPLETED IN MAY THIS
YEAR
OUR CASH POSITION IS STRONG

Source text for Eikon:  ID:nWkr9Wqkc2 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))